Abstract
COVID 19 pandemic has presented a myriad of imaging findings which we need to be aware of to avoid misdiagnosis or overcalling. One such finding, which presents as a diagnostic pitfall and a challenge in oncological imaging is regional uptake post COVID-19 vaccination. We report a case of regional 18 F-fluorodeoxyglucose (FDG) uptake post COVID 19 vaccination. There is need to revise the protocols for imaging, determine the best time to image in the peri-vaccination period and acquire the pertinent history relating to the vaccination during18F-FDG-PET CT (positron emission tomography/computed tomography) examinations.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 4768-4770 |
| Number of pages | 3 |
| Journal | East African Medical Journal |
| Volume | 99 |
| Issue number | 4 |
| Publication status | Published - 17 Jul 2022 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'REACTIVE LYMPHADENOPATHY ON FDG PET CT POST COVID 19 VACCINATION: A POTENTIAL PITFALL AND PRACTICAL CONSIDERATIONS'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver